Corinna Keup
Essen, NW 45147, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient Plasma.
Journal: Journal of extracellular biology
Published: January 29, 2026
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy.
Journal: Scientific reports
Published: November 06, 2024
Gene expression analysis in circulating tumour cells to determine resistance to CDK4/6 inhibitors plus endocrine therapy in HR + /HER2- metastatic breast cancer patients.
Journal: Journal of translational medicine
Published: October 24, 2024
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management.
Journal: Cancers
Published: September 11, 2023
Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer.
Journal: Scientific reports
Published: July 26, 2023
Combinatorial Power of cfDNA, CTCs and EVs in Oncology.
Journal: Diagnostics (Basel, Switzerland)
Published: February 24, 2022
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer.
Journal: Genome medicine
Published: September 29, 2020
Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer.
Journal: Frontiers in oncology
Published: May 20, 2020
Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies.
Journal: Breast care (Basel, Switzerland)
Published: April 29, 2020
Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patients.
Journal: Journal of cellular and molecular medicine
Published: February 25, 2019
Last Updated: 09/26/2026